References
- Hoogkamp-Korstanje J AA. Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy. Eur J Clin Microbiol 1984; 3: 333–338
- Shire L, Saunders J, Traynor R, Koornhof H J. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. Eur J Clin Microbiol 1984; 3: 328–332
- King A, Shannon K, Phillips I. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother 1984; 13: 325–331
- Young L S. Clinical experience with the newer quinolones. Res Clin Forum 1985; 7: 97–102
- Meckenstock R, Haralambie E, Linzenmeier G, Wendt F. Die Beeinflussung der Darmflora durch Norfloxacin bei gesunden Menschen. Z Antimikrob Antineoplast Chemother, Band 3, Heft 1985; 1: 27–34
- Sutter V L, Finegold S M. The effect of antimicrobial agents on human faecal flora: Studies with cephalexin, cyclacillin and clindamycin. The normal microbial flora of man, F A Skinner, J G Carr. Academic Press, London 1974; 229–240
- Nord C E, Heimdahl A, Kager L, Malmborg A-S. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis 1984; 6: 270–275, Suppl. 1
- Nord C E, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76: 99–106
- Bergan T, Engeset A, Olszewski W, Østby N, Solberg R. Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters. Eur J Clin Microbiol 1986; 5: 458–461
- Wagner J G. Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Illinois 1975; 403–437
- Heimdahl A, Nord C E. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 1979; 11: 233–242
- Borthen L, Heimdahl A, Lindqvist L, Nord C E. Determination of volatile fatty acids in saliva and faeces by gas-liquid chromatography—a rapid method for detection of antibiotic-induced changes in the oropharyngeal and gastrointestinal microflora. Int J Microbiol 1983; 1: 35–45
- Swanson B, Boppana V, Vlasses P, Rotmensch H, Ferguson R. Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother 1983; 23: 284–288
- Adhami Z N, Wise R, Weston D, Crump B. The pharmacokinetics and tissue penetration of norfloxacin. J Antimicrob Chemother 1984; 13: 87–92
- Brogard J-M, Jehl F, Monteil H, Adloff M, Blickle J-F, Levy P. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Antimicrob Agents Chemother 1985; 28: 311–314
- Davies R L, Koup J R, Williams-Warren J, Weber A, Smith A L. Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrob Agents Chemother 1985; 28: 74–77
- Gonzalez M A, Uribe F, Moisen S D, Fuster A P, Selen A, Welling P G, Painter B. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1984; 26: 741–744
- Cofsky R D, du Bouchet L, Landsman S H. Recovery of norfloxacin in faeces after administration of a single oral dose to human volunteers. Antimicrob Agents Chemother 1984; 26: 110–111
- Goldstein E, Citron D. Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother 1985; 27: 657–659
- Brumfitt W, Franklin I, Grady D, Hamilton-Miller J MT, Iliffe A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 1984; 26: 757–761
- Nord C E, Delin C, Bergan T, Johansen S, Kolstad I M, Thorsteinsson S B. The effect of ciprofloxacin on oropharyngeal and colon microflora. Res Clin Forum 1985; 7: 89–94
- Rozenberg-Arska M, Dekker A W, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: The effect on fecal flora. J Infect Dis 1985; 152: 104–107